ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2493

Investigating scoring systems to measure clinically relevant changes in systemic sclerosis-related finger acro-osteolysis over time, as assessed in serial hand radiographs

Michael Hughes1, Graham Dinsdale2, Aayushi Agnihotri3, Joanne Manning2, Muditha Samaranayaka4, Jonathan Harris2 and Ariane Herrick5, 1The University of Manchester, Manchester, England, United Kingdom, 2Northern Care Alliance NHS Foundation Trust, Salford, United Kingdom, 3The University of Manchester, Manchester, United Kingdom, 4Salford Royal Hospital, Salford, United Kingdom, 5The University of Manchester, UK, Aberdeen, United Kingdom

Meeting: ACR Convergence 2025

Keywords: Raynaud's, Raynaud's phenomenon, Scleroderma, Scleroderma, Systemic, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2470–2503) Systemic Sclerosis & Related Disorders – Clinical Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Acro-osteolysis (A-O, terminal tuft digit resorption) is characteristic of systemic sclerosis (SSc), occurring in 20-25% of patients (1). Outcome measures are much needed. Following our previous work (2) that developed a scoring system for A-O, our objective was to examine different methods of scoring A-O over time, specifically comparing subjective clinician opinion to more formal digit-by-digit scoring, to investigate their potential as outcome measures.

Methods: Patients identified from a tertiary referral centre for SSc who had a first visit between 2006-2018, who had suitable radiographs (both hands, two time points). The final image set contained 180 image pairs from 90 patients. Radiographs were presented to a single observer for assessment:1. 180 single (blinded) images; 10 fingers/digits scored: 0 (normal) to 4 (complete terminal tuft resorption); total (sum of all digits), maximum, and Johnstone scores (2) calculated.2. 90 image pairs presented (left vs right) in a randomised order. Images reviewed answering “is the acro-osteolysis status of the right-hand image more or less severe than the left-hand image?”: 5-point ordinal scale: much less severe (-2) to much more severe (+2). Images with fewer than 3 classifiable digits per hand were excluded. Missing values in included images were replaced with the average score (mean of all other digits). For paired images the clinician change scores were used to dichotomise: “changers” (patients assessed as changing over time) who were scored “much more severe” (+2) or “more severe” (+1) and “no change” scoring “same” (0), “less severe” (-1), or much less severe (-2). We derived “change over time” data between pairs of images – with change calculated in (1) total score, (2) maximum score, and (3) Johnstone score. We investigated differences in scoring between the “changers” vs. “no change” groups using T-tests (total) or Mann-Whitney tests (maximum, Johnstone).

Results: Patient demographics (n=90) are presented in Table 1. No score could be given in 102/1800 digits assessed due to amputation (n=17, 17%) or obscured digit (n=85, 83%). 10/180 images, and 9/90 pairs were excluded due to missing data. 81 image pairs were analysed after meeting our criteria, with 25 ultimately labelled as “changers”, and 56 labelled as “no change”. Figure 1: box plots comparing change-over-time data (total, max, or Johnstone) between the two groups from the dichotomised subjective clinician change score. A significant difference in change in total score of >6 points is identified between the two groups.

Conclusion: Total score appears to show promise for measuring clinically relevant change in A-O. Maximum and Johnstone scores are less sensitive with no obvious difference in group medians (despite statistical significance), likely due to the relatively large number of cases with zero change in both groups. We have explored pragmatic options for quantifying clinically relevant change in A-O with relevance to future longitudinal studies including impact of treatment. References1. Avouac, et al. Ann Rheum Dis 2006:1088–92. 2. Johnstone, et al. Rheumatology 2012;:2234–8.

Supporting image 1Table 1. Patient demographics.

Supporting image 2Figure 1. Boxplots comparing changers and no change groups as defined by clinician opinion (paired image assessment): a) Change in total score, b) change in maximum score, and c) change in Johnstone score. Comparisons of means/medians for a, b and c are shown bottom right, with p-values from T-test or Mann-Whitney tests as appropriate.


Disclosures: M. Hughes: Janssen, 5, 6; G. Dinsdale: None; A. Agnihotri: None; J. Manning: None; M. Samaranayaka: None; J. Harris: None; A. Herrick: Abbvie, 2, Boehringer-Ingelheim, 2, Janssen, 2, 6, Zura Bio, 2.

To cite this abstract in AMA style:

Hughes M, Dinsdale G, Agnihotri A, Manning J, Samaranayaka M, Harris J, Herrick A. Investigating scoring systems to measure clinically relevant changes in systemic sclerosis-related finger acro-osteolysis over time, as assessed in serial hand radiographs [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/investigating-scoring-systems-to-measure-clinically-relevant-changes-in-systemic-sclerosis-related-finger-acro-osteolysis-over-time-as-assessed-in-serial-hand-radiographs/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/investigating-scoring-systems-to-measure-clinically-relevant-changes-in-systemic-sclerosis-related-finger-acro-osteolysis-over-time-as-assessed-in-serial-hand-radiographs/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology